These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 34307635)
1. Corrigendum to "Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases". Sang LX World J Clin Cases; 2021 Jul; 9(20):5752-5753. PubMed ID: 34307635 [TBL] [Abstract][Full Text] [Related]
2. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. Cheng FS; Pan D; Chang B; Jiang M; Sang LX World J Clin Cases; 2020 Apr; 8(8):1361-1384. PubMed ID: 32368530 [TBL] [Abstract][Full Text] [Related]
3. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity. Biagioli M; Laghi L; Carino A; Cipriani S; Distrutti E; Marchianò S; Parolin C; Scarpelli P; Vitali B; Fiorucci S Front Pharmacol; 2017; 8():505. PubMed ID: 28804459 [No Abstract] [Full Text] [Related]
6. Evaluation of the efficacy of probiotic VSL#3 and synbiotic VSL#3 and yacon-based product in reducing oxidative stress and intestinal permeability in mice induced to colorectal carcinogenesis. Cruz BCDS; de Sousa Moraes LF; De Nadai Marcon L; Dias KA; Murad LB; Sarandy MM; Conceição LLD; Gonçalves RV; Ferreira CLLF; Peluzio MDCG J Food Sci; 2021 Apr; 86(4):1448-1462. PubMed ID: 33761141 [TBL] [Abstract][Full Text] [Related]
7. VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects. Krishnan M; Penrose HM; Shah NN; Marchelletta RR; McCole DF Inflamm Bowel Dis; 2016 Dec; 22(12):2811-2823. PubMed ID: 27824650 [TBL] [Abstract][Full Text] [Related]
8. Amelioration of intestinal and systemic sequelae of murine Ekmekciu I; Fiebiger U; Stingl K; Bereswill S; Heimesaat MM Gut Pathog; 2017; 9():17. PubMed ID: 28413453 [TBL] [Abstract][Full Text] [Related]
9. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Caballero-Franco C; Keller K; De Simone C; Chadee K Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G315-22. PubMed ID: 16973917 [TBL] [Abstract][Full Text] [Related]
10. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928 [TBL] [Abstract][Full Text] [Related]
11. Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(-/-) mice. Chan YK; El-Nezami H; Chen Y; Kinnunen K; Kirjavainen PV AMB Express; 2016 Dec; 6(1):61. PubMed ID: 27576894 [TBL] [Abstract][Full Text] [Related]
12. Probiotic Mixture VSL#3 Alleviates Dextran Sulfate Sodium-induced Colitis in Mice by Downregulating T Follicular Helper Cells. Liu XJ; Yu R; Zou KF Curr Med Sci; 2019 Jun; 39(3):371-378. PubMed ID: 31209805 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Ng SC; Plamondon S; Kamm MA; Hart AL; Al-Hassi HO; Guenther T; Stagg AJ; Knight SC Inflamm Bowel Dis; 2010 Aug; 16(8):1286-98. PubMed ID: 20155842 [TBL] [Abstract][Full Text] [Related]
15. The probiotic mixture VSL#3 mediates both pro- and anti-inflammatory responses in bone marrow-derived dendritic cells from C57BL/6 and BALB/c mice. Mariman R; Kremer B; Koning F; Nagelkerken L Br J Nutr; 2014 Oct; 112(7):1088-97. PubMed ID: 25181025 [TBL] [Abstract][Full Text] [Related]